Fashion does not exist in a bubble — it reflects the wider culture (for better or worse) and this was clearly evident on the ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

BofA analyst Allen Lutz notes that the Food and Drug Administration yesterday provided updated enforcement timelines for semaglutide and ...

Reports Q4 revenue $64.3M, consensus $57.4M. “LifeMD (LFMD) had a great fourth quarter. We not only achieved record quarterly revenue and ...

In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...